Status:
COMPLETED
Early Short-term Antibiotic Therapy in Penetrating Abdominal Trauma, 3 vs 7 Days
Lead Sponsor:
Silvia M. Pinango L.
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
SURGICAL SITE INFECTION
Eligibility:
All Genders
12-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Abdominal penetrating trauma represents a frequent cause of consult into emergency rooms in Venezuela. Accidents and violence at Hospital "Miguel Perez Carreño" along april 2009 were represented by gu...
Detailed Description
General objectives The object of this research is to evaluated the impact of Early short-term antibiotic therapy with Ertapenem, 3 vs 7 days, upon clinical postoperatory evolution in patients with pen...
Eligibility Criteria
Inclusion
- Patients with penetrating abdominal trauma who attended the emergency room within 12 hours after trauma, admitted to an exploratory laparotomy.
- Patients aged 12 to 65 years.
Exclusion
- Clinical history of immunologic diseases, cancer, use of immunosuppressors, steroids, malnutrition, morbid obesity.
- Concomitant pathology at admittance: urinary infections, respiratory infections, hepatitis, viral diseases.
- Associated open bone fractures.
- Patients with hemodynamic instability during pre or peroperative.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT01203046
Start Date
December 1 2010
End Date
October 1 2011
Last Update
August 10 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.